Charles Schwab’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.3M Buy
374,613
+5,150
+1% +$855K 0.01% 1077
2026
Q1
$62.6M Buy
369,463
+4,345
+1% +$738K 0.01% 1003
2025
Q4
$56M Sell
365,118
-1,680
-0.5% -$256K 0.01% 1067
2025
Q3
$55M Sell
366,798
-1,675
-0.5% -$264K 0.01% 1105
2025
Q2
$58.7M Sell
368,473
-1,271
-0.3% -$206K 0.01% 1002
2025
Q1
$61.4M Sell
369,744
-1,168
-0.3% -$192K 0.01% 935
2024
Q4
$60.5M Buy
370,912
+8,942
+2% +$1.55M 0.01% 996
2024
Q3
$63.7M Buy
361,970
+7,562
+2% +$1.29M 0.01% 932
2024
Q2
$54.6M Buy
354,408
+12,879
+4% +$1.94M 0.01% 1005
2024
Q1
$52.9M Buy
341,529
+10,423
+3% +$1.55M 0.01% 1004
2023
Q4
$49.3M Buy
331,106
+9,787
+3% +$1.25M 0.01% 988
2023
Q3
$39.9M Buy
321,319
+11,719
+4% +$1.56M 0.01% 1049
2023
Q2
$41.7M Buy
309,600
+5,523
+2% +$710K 0.01% 981
2023
Q1
$38.5M Buy
304,077
+4,700
+2% +$608K 0.01% 1006
2022
Q4
$36.6M Buy
299,377
+6,928
+2% +$915K 0.01% 1013
2022
Q3
$35.6M Buy
292,449
+20,708
+8% +$2.7M 0.01% 979
2022
Q2
$35.3M Sell
271,741
-1,136
-0.4% -$142K 0.01% 989
2022
Q1
$37.3M Buy
272,877
+7,966
+3% +$1.14M 0.01% 1071
2021
Q4
$44.7M Buy
264,911
+3,191
+1% +$512K 0.01% 976
2021
Q3
$38M Buy
261,720
+3,275
+1% +$443K 0.01% 1060
2021
Q2
$33.9M Buy
258,445
+6,336
+3% +$815K 0.01% 1156
2021
Q1
$31.6M Buy
252,109
+5,719
+2% +$695K 0.01% 1152
2020
Q4
$28.4M Buy
246,390
+2,976
+1% +$314K 0.01% 1148
2020
Q3
$23.8M Sell
243,414
-4,641
-2% -$455K 0.01% 1086
2020
Q2
$23.5M Sell
248,055
-5,590
-2% -$523K 0.01% 1057
2020
Q1
$25M Buy
253,645
+7,054
+3% +$723K 0.01% 858
2019
Q4
$25.1M Buy
246,591
+15,503
+7% +$1.56M 0.01% 1059
2019
Q3
$22.9M Buy
231,088
+10,373
+5% +$988K 0.01% 1044
2019
Q2
$22.1M Buy
220,715
+3,927
+2% +$382K 0.01% 1067
2019
Q1
$20.1M Buy
216,788
+10,622
+5% +$916K 0.01% 1102
2018
Q4
$16.2M Buy
206,166
+785
+0.4% +$70.9K 0.01% 1130
2018
Q3
$23M Buy
205,381
+9,452
+5% +$994K 0.02% 1055
2018
Q2
$19.2M Buy
195,929
+11,664
+6% +$1.09M 0.01% 1111
2018
Q1
$15.1M Buy
184,265
+14,146
+8% +$1.11M 0.01% 1194
2017
Q4
$13.7M Buy
170,119
+16,782
+11% +$1.4M 0.01% 1264
2017
Q3
$12.5M Buy
153,337
+8,582
+6% +$659K 0.01% 1259
2017
Q2
$11.2M Buy
144,755
+8,826
+6% +$704K 0.01% 1259
2017
Q1
$11.2M Buy
135,929
+12,200
+10% +$1.03M 0.01% 1236
2016
Q4
$10.4M Buy
123,729
+4,576
+4% +$361K 0.01% 1221
2016
Q3
$9.24M Buy
119,153
+8,612
+8% +$572K 0.01% 1227
2016
Q2
$6.59M Buy
110,541
+1,956
+2% +$120K 0.01% 1374
2016
Q1
$6.74M Buy
108,585
+2,506
+2% +$150K 0.01% 1318
2015
Q4
$6.45M Buy
106,079
+4,682
+5% +$304K 0.01% 1337
2015
Q3
$6.16M Buy
101,397
+2,397
+2% +$139K 0.01% 1332
2015
Q2
$5.52M Buy
99,000
+11,010
+13% +$634K 0.01% 1483
2015
Q1
$4.87M Buy
87,990
+6,452
+8% +$369K 0.01% 1525
2014
Q4
$5.43M Buy
81,538
+129
+0.2% +$8.05K 0.01% 1381
2014
Q3
$4.61M Sell
81,409
-86
-0.1% -$4.58K 0.01% 1434
2014
Q2
$4.37M Buy
81,495
+1,768
+2% +$101K 0.01% 1509
2014
Q1
$4.16M Sell
79,727
-6,344
-7% -$341K 0.01% 1480
2013
Q4
$5.05M Buy
86,071
+5,116
+6% +$289K 0.01% 1244
2013
Q3
$4.18M Buy
80,955
+3,037
+4% +$150K 0.01% 1312
2013
Q2
$3.52M Buy
+77,918
New +$3.48M 0.01% 1340

Other funds holding BCPC

Charles Schwab's BCPC Position: Q2 2026 in Review

Charles Schwab increased its Balchem Corp (BCPC) stake by 1.4% in Q2 2026, buying an estimated $855K and bringing the position to 374,613 shares worth $63.3M. The position accounts for 0.01% of the portfolio, ranked #1077.

Charles Schwab first reported a position in BCPC in Q2 2013 and has held it in 53 quarters since. The position peaked at $63.7M in Q3 2024. 416 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

  • Charles Schwab held 374,613 shares of Balchem Corp worth $63.3M as of Q2 2026.
  • Charles Schwab bought 5,150 Balchem Corp shares in Q2 2026, an estimated $855K.
  • Balchem Corp made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1077 holding.
  • Charles Schwab first reported a position in Balchem Corp in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Balchem Corp position peaked at $63.7M in Q3 2024.
  • 416 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.